CHRISTINE KING: Open Payments
NPI 1922886696 · LORAIN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$876 in 20 payments from 8 companies in 2025. Trend: 2023 $463 · 2024 $181 · 2025 $876
Food & beverage: $876
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $218 |
| ABBVIE INC. | 6 | $203 |
| Alkermes, Inc. | 3 | $151 |
| Janssen Pharmaceuticals, Inc | 1 | $127 |
| E.R. Squibb & Sons, L.L.C. | 3 | $68 |
| Otsuka America Pharmaceutical, Inc. | 2 | $47 |
| Teva Pharmaceuticals USA, Inc. | 2 | $41 |
| Lundbeck LLC | 1 | $22 |
Products named: CAPLYTA, VRAYLAR, ARISTADA, INVEGA SUSTENNA, COBENFY, ABILIFY MAINTENA, UZEDY, ABILIFY ASIMTUFII.
Industry payments across OH — which companies pay providers there.
